WASHINGTON D.C., United States – May 2018: On 30 May 2018, the United States Drug Enforcement Administration (DEA) notified of the intent to issue a temporary order adding the five synthetic cannabinoids NM-2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA to Schedule I, pursuant to the provisions of the Controlled Substances Act (CSA). Substances in Schedule I of the CSA are those that have a high potential for abuse, no accepted medical use in present treatment in the United States, and a lack of accepted safety for use under medical supervision. The temporary scheduling order will be published in the Federal Register on or after 29 June 2018.
For more information, please see:
Federal Register of the United States Government – Schedules of Controlled Substances: Temporary Placement of NM2201, 5F-AB-PINACA, 4-CN-CUMYL-BUTINACA, MMB-CHMICA and 5F-CUMYL-P7AICA Into Schedule I
UNODC Recommended methods for the Identification and Analysis of Synthetic Cannabinoid Receptor Agonists in Seized Materials – Available in: English, French, Russian and Spanish
UNODC Global SMART Update Volume 13 – “Synthetic cannabinoids: Key facts about the largest and most dynamic group of NPS”